Outset Medical, Inc.
Outset Medical, Inc. (Nasdaq: OM) is a medical technology company that develops and sells the Tablo Hemodialysis System for patients with acute or chronic kidney failure. The FDA-cleared system is designed for use in hospitals, clinics and homes, combining a compact dialysis console with integrated water purification,… From the company’s description.
Over the twelve months to Sep 30, 2026, Outset Medical, Inc. reported revenue of $121.97M, up 1.6% from a year earlier, and a net loss of $71.14M. Its operating margin was −51.2%, and operations used $42.38M in cash. In fiscal 2025, it reported revenue of $119.48M, up 5.1% from fiscal 2024, and a net loss of $81.65M.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Outset Medical, Inc. does
In the company’s own words
Outset Medical, Inc. (Nasdaq: OM) is a medical technology company that develops and sells the Tablo Hemodialysis System for patients with acute or chronic kidney failure. The FDA-cleared system is designed for use in hospitals, clinics and homes, combining a compact dialysis console with integrated water purification, on-demand dialysate production, a single-use cartridge and connected software. Its cloud-based tools support remote device monitoring, treatment data access, patient analytics and clinical recordkeeping. Customers include hospitals, dialysis providers, skilled nursing facilities, long-term acute care hospitals and home-dialysis patients and providers. Outset also supports hospitals seeking to establish and operate in-house dialysis services. The company’s product portfolio includes Tablo Console, Tablo Cartridge and the Tablo data ecosystem, including the TabloHub provider portal, MyTablo patient portal and TabloDash analytics platform. Tablo is its core business, and the filing describes no separate reportable operating segments.
Company details
- Sector
- Health Care
- Industry (SIC)
- Electromedical Apparatus
- Headquarters
- SAN JOSE, CA
- Fiscal year end
- December
- CIK
- 1484612
- SIC
- 3845
Financial performance, year by year
Fiscal 2020–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Outset Medical, Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · Outset Medical, Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Could not be determined for this company: bond issues.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Outset Medical, Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Outset Medical, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Outset Medical, Inc.'s last four quarterly filings that the numbers alone won't show?”